Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 268

The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.

Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targets

Open access
Tang, Fanying, Xu, Duo, Wang, Shangqian, Wong, Chen Khuan, Martinez-Fundichely, Alexander, Lee, Cindy J., Cohen, Sandra, Park, Jane, Hill, Corinne E., Eng, Kenneth, Bareja, Rohan, Han, Teng, Liu, Eric Minwei, Palladino, Ann, Di, Wei, Gao, Dong, Abida, Wassim, Beg, Shaham, Puca, Loredana, Meneses, Maximiliano, de Stanchina, Elisa, Berger, Michael F., Gopalan, Anuradha, Dow, Lukas E., Mosquera, Juan Miguel, Beltran, Himisha, Sternberg, Cora N., Chi, Ping, Scher, Howard I., Sboner, Andrea, Chen, Yu, Khurana, Ekta·2022·Science

Abstract

In castration-resistant prostate cancer (CRPC), the loss of androgen receptor (AR) dependence leads to clinically aggressive tumors with few therapeutic options. We used ATAC-seq (assay for transposase-accessible chromatin sequencing), RNA-seq, and DNA sequencing to investigate 22 organoids, six patient-derived xenografts, and 12 cell lines. We identified the well-characterized AR-dependent and neuroendocrine subtypes, as well as two AR-negative/low groups: a Wnt-dependent subtype, and a stem cell–like (SCL) subtype driven by activator protein–1 (AP-1) transcription factors. We used transcriptomic signatures to classify 366 patients, which showed that SCL is the second most common subtype of CRPC after AR-dependent. Our data suggest that AP-1 interacts with the YAP/TAZ and TEAD proteins to maintain subtype-specific chromatin accessibility and transcriptomic landscapes in this group. Together, this molecular classification reveals drug targets and can potentially guide therapeutic decisions.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1126/science.abe1505

Cites

80 of 80 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 80 references

Cited by

See all 268

Metadata

Authors
Tang, F., Xu, D., Wang, S., Wong, C. K., Martinez-Fundichely, A., Lee, C. J., Cohen, S., Park, J., Hill, C. E., Eng, K., Bareja, R., Han, T., Liu, E. M., Palladino, A., Di, W., Gao, D., Abida, W., Beg, S., Puca, L., Meneses, M., de Stanchina, E., Berger, M. F., Gopalan, A., Dow, L. E., Mosquera, J. M., Beltran, H., Sternberg, C. N., Chi, P., Scher, H. I., Sboner, A., Chen, Y., & Khurana, E.
Venue
Science
Published
2022-05-27
Volume
376
Issue
6596
Pages
eabe1505-eabe1505
ISSN
  • 0036-8075 (ISSN-L)
  • 1095-9203
OpenAlex
W4281564034
Cited by
268
References
80
FWCI
30.30
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targets. https://app.cochat.ai/papers/10.1126/science.abe1505
The paper
Tang, F., Xu, D., Wang, S., Wong, C. K., Martinez-Fundichely, A., Lee, C. J., Cohen, S., Park, J., Hill, C. E., Eng, K., Bareja, R., Han, T., Liu, E. M., Palladino, A., Di, W., Gao, D., Abida, W., Beg, S., Puca, L., . . . Khurana, E. (2022). Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targets. Science. https://doi.org/10.1126/science.abe1505

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.